See more : Altareit SCA (AREIT.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Epigenomics AG (EPGNY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Epigenomics AG, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Shinhokoku Material Corp. (5542.T) Income Statement Analysis – Financial Results
- RB Global, Inc. (RBA) Income Statement Analysis – Financial Results
- Tuscan Holdings Corp. II (THCAW) Income Statement Analysis – Financial Results
- Endurance RP Limited (RPGLF) Income Statement Analysis – Financial Results
- Nintendo Co., Ltd. (NTDOY) Income Statement Analysis – Financial Results
Epigenomics AG (EPGNY)
About Epigenomics AG
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.20M | 842.00K | 1.13M | 1.53M | 1.86M | 4.20M | 2.08M | 1.51M | 1.59M | 1.04M | 1.44M | 1.79M | 4.26M | 2.59M | 0.00 | 3.50M | 9.59M | 7.93M | 10.78M |
| Cost of Revenue | 136.00K | 145.00K | 253.00K | 440.00K | 246.00K | 1.63M | 1.18M | 731.00K | 487.00K | 292.00K | 357.00K | 474.00K | 2.80M | 1.70M | -648.00K | -2.94M | 7.69M | 5.76M | 5.34M |
| Gross Profit | 6.07M | 697.00K | 872.00K | 1.09M | 1.62M | 2.57M | 907.00K | 776.00K | 1.10M | 747.00K | 1.08M | 1.31M | 1.46M | 888.00K | 648.00K | 6.45M | 1.90M | 2.17M | 5.44M |
| Gross Profit Ratio | 97.81% | 82.78% | 77.51% | 71.30% | 86.80% | 61.10% | 43.56% | 51.49% | 69.33% | 71.90% | 75.16% | 73.48% | 34.32% | 34.34% | 0.00% | 183.96% | 19.85% | 27.40% | 50.45% |
| Research & Development | 3.11M | 3.66M | 7.34M | 6.42M | 4.33M | 5.12M | 5.76M | 4.69M | 4.38M | 8.02M | 4.95M | 7.22M | 7.35M | 10.03M | -4.22M | -3.18M | 8.12M | 7.79M | 7.64M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.25M | 5.15M | 4.91M | 4.51M | 5.52M | 5.94M | 5.78M | 3.27M | 3.44M | 0.00 | 0.00 | 3.84M | 3.71M | 3.21M |
| Selling & Marketing | 4.44M | 3.47M | 4.52M | 4.18M | 4.67M | 0.00 | 0.00 | 0.00 | 4.51M | 0.00 | 0.00 | 0.00 | 1.19M | 857.00K | -531.00K | -1.65M | 1.52M | 1.32M | 1.31M |
| SG&A | 4.44M | 3.47M | 4.52M | 4.18M | 4.67M | 10.25M | 5.15M | 4.91M | 9.02M | 5.52M | 5.94M | 5.78M | 4.46M | 4.30M | -531.00K | -1.65M | 5.37M | 5.03M | 4.52M |
| Other Expenses | 2.68M | 3.69M | 4.11M | 3.79M | 2.48M | -361.00K | -727.00K | -482.00K | -5.09M | -682.00K | 5.44M | -239.00K | -127.00K | -689.00K | 0.00 | 0.00 | -21.82M | -20.52M | -12.99M |
| Operating Expenses | 10.23M | 10.81M | 15.97M | 14.39M | 11.47M | 15.01M | 10.18M | 9.11M | 8.30M | 12.85M | 16.33M | 12.76M | 11.68M | 13.64M | -4.75M | -4.82M | -8.33M | -7.70M | -833.00K |
| Cost & Expenses | 10.37M | 10.96M | 16.23M | 14.83M | 11.72M | 16.64M | 11.36M | 9.84M | 8.79M | 13.15M | 16.68M | 13.24M | 14.48M | 15.34M | -5.40M | 19.27M | -640.00K | -1.94M | 4.51M |
| Interest Income | 12.00K | 21.00K | 172.00K | 17.00K | 18.00K | 17.00K | 18.00K | 19.00K | 22.00K | 104.00K | 219.00K | 165.00K | 191.00K | 682.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 52.00K | 55.00K | 63.00K | 550.00K | 175.00K | 0.00 | 2.00K | 516.00K | 33.00K | 0.00 | 0.00 | 0.00 | 8.00K | 30.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 419.00K | 535.00K | 513.00K | 308.00K | 343.00K | 356.00K | 668.00K | 770.00K | 799.00K | 923.00K | 4.31M | 1.14M | 776.00K | 2.51M | 1.25M | 1.57M | 1.67M | 1.44M | 1.35M |
| EBITDA | -1.94M | -11.07M | -13.99M | -12.57M | -9.93M | -11.94M | -8.58M | -7.60M | -6.45M | -11.12M | -11.01M | -10.29M | -9.24M | -9.52M | 6.65M | -13.83M | 9.24M | 11.88M | 8.02M |
| EBITDA Ratio | -31.26% | -1,315.08% | -1,243.56% | -820.09% | -532.78% | -284.22% | -412.06% | -503.98% | -405.86% | -1,070.26% | -766.32% | -576.05% | -216.83% | -368.21% | 0.00% | -394.81% | 96.32% | 149.82% | 74.44% |
| Operating Income | -2.36M | -11.63M | -14.67M | -12.90M | -10.29M | -12.31M | -9.26M | -8.38M | -7.29M | -12.12M | -15.25M | -11.45M | -10.22M | -12.75M | -13.50M | -15.76M | 10.23M | 9.87M | 6.27M |
| Operating Income Ratio | -38.01% | -1,380.88% | -1,304.27% | -841.16% | -551.98% | -293.07% | -444.96% | -556.27% | -458.94% | -1,166.79% | -1,060.89% | -640.68% | -239.86% | -493.04% | 0.00% | -449.80% | 106.67% | 124.42% | 58.18% |
| Total Other Income/Expenses | -52.00K | -36.00K | 107.00K | -535.00K | -160.00K | 16.00K | 15.00K | -498.00K | 11.00K | 80.00K | -73.00K | 13.00K | 197.00K | 692.00K | 0.00 | 0.00 | -226.00K | 569.00K | 399.00K |
| Income Before Tax | -2.41M | -11.66M | -14.57M | -13.43M | -10.45M | -12.30M | -9.25M | -8.88M | -7.28M | -12.04M | -15.32M | -11.44M | -10.02M | -12.06M | 0.00 | 0.00 | 10.01M | 10.44M | 6.67M |
| Income Before Tax Ratio | -38.85% | -1,385.15% | -1,294.76% | -876.06% | -560.57% | -292.69% | -444.24% | -589.32% | -458.25% | -1,159.10% | -1,065.97% | -639.96% | -235.23% | -466.28% | 0.00% | 0.00% | 104.32% | 131.60% | 61.89% |
| Income Tax Expense | 18.00K | 23.00K | 2.45M | -738.00K | -214.00K | -1.14M | -264.00K | -27.00K | 134.00K | 154.00K | 257.00K | 40.00K | 202.00K | 213.00K | 0.00 | 0.00 | -1.22M | -55.00K | -40.00K |
| Net Income | -2.43M | -11.69M | -17.02M | -12.69M | -10.24M | -11.16M | -8.99M | -8.85M | -7.41M | -12.20M | -15.58M | -11.48M | -10.22M | -12.27M | 0.00 | -15.40M | 8.79M | 10.49M | 6.71M |
| Net Income Ratio | -39.14% | -1,387.89% | -1,512.89% | -827.92% | -549.09% | -265.67% | -431.56% | -587.52% | -466.69% | -1,173.92% | -1,083.86% | -642.19% | -239.98% | -474.52% | 0.00% | -439.55% | 91.60% | 132.30% | 62.26% |
| EPS | -0.27 | -2.48 | -4.48 | -4.48 | -3.93 | -4.90 | -4.67 | -5.77 | -5.53 | -11.27 | -14.39 | -2.31 | -2.86 | -3.85 | 0.00 | -7.42 | 4.37 | 6.20 | 6.48 |
| EPS Diluted | -0.27 | -2.48 | -4.48 | -4.48 | -3.93 | -4.90 | -4.67 | -5.77 | -5.53 | -11.27 | -14.39 | -2.31 | -2.86 | -3.85 | 0.00 | -7.42 | 4.37 | 6.20 | 6.48 |
| Weighted Avg Shares Out | 8.97M | 4.71M | 3.80M | 2.83M | 2.60M | 2.28M | 1.92M | 1.53M | 1.34M | 1.08M | 1.08M | 4.96M | 3.58M | 3.19M | 2.24M | 2.08M | 2.01M | 1.69M | 1.04M |
| Weighted Avg Shares Out (Dil) | 8.97M | 4.71M | 3.80M | 2.83M | 2.60M | 2.28M | 1.92M | 1.53M | 1.34M | 1.08M | 1.08M | 4.96M | 3.58M | 3.19M | 2.24M | 2.08M | 2.01M | 1.69M | 1.04M |
Source: https://incomestatements.info
Category: Stock Reports